newsfilter
← Latest News
Business Wire·

MyMD Pharmaceuticals to Detail its Two Upcoming Phase 2 Trials at the Benzinga Rising Stars: Catalytic Small Cap Growth Conference on October 7

MyMD to launch two simultaneous Phase 2 trials during the current quarter to study MYMD-1's function in extending healthy lifespan and treating COVID-19-associated depression MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) ("MyMD" or "the Company"), a clin